John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOOD
2026
Gladstone Commercial Corp
GOOD
$635M
| $477K | ﹤0.01% |
21,661
-38,090
| -64% | -$855K |
|
2027
Douglas Dynamics
PLOW
$962M
| $476K | ﹤0.01% |
+13,774
| New | +$501K |
|
2028
SmartFinancial
SMBK
$869M
| $476K | ﹤0.01% |
18,617
-7,800
| -30% | -$207K |
|
2029
CNO Financial Group
CNO
$5.01B
| $475K | ﹤0.01% |
+18,934
| New | +$469K |
|
|
RADI
2030
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $474K | ﹤0.01% |
33,198
-593,030
| -95% | -$8.27M |
|
2031
Vivid Seats
SEAT
$81.9M
| $471K | ﹤0.01% |
+2,130
| New | +$454K |
|
|
SF
2032
Stifel
SF
$12B
| $470K | ﹤0.01% |
10,392
-59,585
| -85% | -$2.86M |
|
2033
Washington Trust Bancorp
WASH
$755M
| $470K | ﹤0.01% |
+8,953
| New | +$500K |
|
|
BDN
2034
Brandywine Realty Trust
BDN
$565M
| $469K | ﹤0.01% |
+33,200
| New | +$449K |
|
2035
TriplePoint Venture Growth BDC
TPVG
$217M
| $469K | ﹤0.01% |
26,841
-35,266
| -57% | -$598K |
|
|
OLP
2036
One Liberty Properties
OLP
$538M
| $468K | ﹤0.01% |
+15,209
| New | +$471K |
|
2037
FS Bancorp
FSBW
$336M
| $467K | ﹤0.01% |
15,071
+8,610
| +133% | +$280K |
|
|
TBNK
2038
DELISTED
Territorial Bancorp Inc.
TBNK
| $467K | ﹤0.01% |
19,438
+840
| +5% | +$20.9K |
|
2039
Douglas Emmett
DEI
$2.04B
| $466K | ﹤0.01% |
+13,942
| New | +$457K |
|
2040
Bridgewater Bancshares
BWB
$589M
| $464K | ﹤0.01% |
27,811
+9,055
| +48% | +$158K |
|
2041
Concrete Pumping Holdings
BBCP
$478M
| $463K | ﹤0.01% |
69,177
-34,870
| -34% | -$268K |
|
2042
Regis Corp
RGS
$66.8M
| $462K | ﹤0.01% |
10,891
-5,234
| -32% | -$182K |
|
|
TRUE
2043
DELISTED
TrueCar
TRUE
| $462K | ﹤0.01% |
+116,945
| New | +$413K |
|
2044
Enliven Therapeutics
ELVN
$4.47B
| $459K | ﹤0.01% |
61,036
-4,515
| -7% | -$29.8K |
|
2045
Neurogene
NGNE
$817M
| $459K | ﹤0.01% |
12,199
+4,404
| +56% | +$257K |
|
|
LCI
2046
DELISTED
Lannett Company, Inc.
LCI
| $459K | ﹤0.01% |
145,496
+26,545
| +22% | +$117K |
|
2047
Bank of Hawaii
BOH
$3B
| $458K | ﹤0.01% |
5,455
-328
| -6% | -$28.3K |
|
2048
Dianthus Therapeutics
DNTH
$6.27B
| $458K | ﹤0.01% |
9,864
-1
| -0% | -$55 |
|
2049
Five Star Bancorp
FSBC
$1.1B
| $458K | ﹤0.01% |
16,177
-1,029
| -6% | -$31K |
|
2050
Pangaea Logistics
PANL
$549M
| $458K | ﹤0.01% |
+82,405
| New | +$387K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.